CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 137 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $374,000 | -10.5% | 19,000 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $418,000 | +11.2% | 19,000 | +20.3% | 0.01% | 0.0% |
| Q1 2021 | $376,000 | -9.0% | 15,800 | 0.0% | 0.01% | -22.2% |
| Q4 2020 | $413,000 | +36.3% | 15,800 | -9.2% | 0.01% | +28.6% |
| Q3 2020 | $303,000 | -43.4% | 17,400 | -61.8% | 0.01% | 0.0% |
| Q1 2019 | $535,000 | -34.8% | 45,600 | -25.7% | 0.01% | -36.4% |
| Q4 2018 | $820,000 | +88.5% | 61,400 | +98.1% | 0.01% | +175.0% |
| Q3 2018 | $435,000 | -10.7% | 31,000 | 0.0% | 0.00% | -20.0% |
| Q2 2018 | $487,000 | -4.5% | 31,000 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $510,000 | -22.3% | 31,000 | -14.6% | 0.01% | -28.6% |
| Q4 2017 | $656,000 | -10.1% | 36,300 | -4.0% | 0.01% | -12.5% |
| Q3 2017 | $730,000 | +19.7% | 37,800 | -26.9% | 0.01% | +14.3% |
| Q2 2017 | $610,000 | +7.6% | 51,700 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $567,000 | +51.2% | 51,700 | 0.0% | 0.01% | +40.0% |
| Q4 2016 | $375,000 | – | 51,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,609,429 | $55,961,000 | 3.12% |
| INVESTOR AB | 1,835,974 | $11,934,000 | 0.86% |
| GLOBEFLEX CAPITAL L P | 244,183 | $1,587,000 | 0.40% |
| Campbell & CO Investment Adviser LLC | 21,446 | $139,000 | 0.37% |
| Birchview Capital, LP | 80,000 | $520,000 | 0.30% |
| FEDERATED HERMES, INC. | 13,879,968 | $90,220,000 | 0.26% |
| MENTA CAPITAL LLC | 388,582 | $2,526,000 | 0.24% |
| Sitrin Capital Management LLC | 40,000 | $260,000 | 0.20% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 172,389 | $1,121,000 | 0.18% |
| GSA CAPITAL PARTNERS LLP | 384,976 | $2,502,000 | 0.13% |